News
Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
Moderna Inc. said it has “voluntarily” withdrawn its application for regulatory approval for its combination Covid and flu ...
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...
4d
Live Science on MSN2-in-1 COVID-flu vaccine looks promising, but approval could be delayedLate-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect ...
With Covid cases resurfacing, the District Health Department has started monitoring cases of influenza and seasonal flu more ...
This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing ...
The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
May 21 (Reuters) - Moderna (MRNA.O), opens new tab said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the ...
The upcoming changes raise questions for people who may still want a fall COVID-19 shot but aren't 65 or older or have at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results